The FDA authorized both companies to begin U.S. studies in children 11 and under. Eventually, the FDA hopes to vaccinate children as young as 6-months.
AstraZeneca is reportedly studying its vaccine among 6-to-17-year-olds in the UK. Johnson & Johnson is also preparing pediatric studies of their COVID-19 vaccine.
